day 1 agenda

Mon , Nov 06, 2023

  • 09:00-09:15
  • Opening Ceremony

  • 09:15-09:45
  • Keynote Speech -1

    Jaimin R. Shah, Moores Cancer Center, University of California San Diego, United States

    Title: Encapsulated Oncolytic Adenovirus for the Treatment of Breast Cancer

  • 09:45-10:15
  • Keynote Speech -2

    Ruben Abagyan, University of California, United States

    Title: Rapid discovery of new target profiles and lead candidates for the cancer therapies

  • 10:15-10:45
  • Keynote Speech -3

    TBA

  • 10:45-11:00
  • Group Photo & Refreshment Break

  • 11:00-13:00
  • Morning Session

  • 11:00-11:20
  • Talk-1

    Ryan Shaler, Sonata Therpeutics, United States

    Title: Delineating the Mechanisms of Immunogenic Cell Death in Immuno-oncology: A Comparative Examination of the Complexities Associated with Murine-to-Human Translation

  • 11:20-11:40
  • Talk-2

    Baofa Yu, Immune ONcology Systems, Inc., United States

    Title: Awaken Immune Cells by Hapten Enhanced Intratumoral Chemotherapy with Penicillin Prolong Pancreatic Cancer Survival

  • 11:40-12:00
  • Talk-3

    Yi Zhang, Beijing Tongren Hospital/Capital Medical University, China

    Title: Clinical characteristics, treatment and prognosis of infants with retinoblastoma: a multicenter, 10-year retrospective analysis

  • 12:00-12:20
  • Talk-4

    Hee Sung Park, Gyeongsang National University, South Korea

    Title: Combination effects of autocrine motility factor and tamoxifen on triple negative breast cancer cells

  • 12:20-12:40
  • Talk-5

    Valentina Bugani, IRCCS IRST, Italy

    Title: Radioligand therapies in cancer: mapping the educational landscape in Europe

  • 12:40-13:00
  • Talk-6

    Sonia Gupte, Mind Medicine Movement USA & EKAA Training Institute of Hypnotherapy India, United States

    Title: Medical Hypnosis and it's relevance in Oncology 

  • 13:00-14:00
  • Lunch Break

  • 14:00-17:10
  • Afternoon Session

  • 14:00-14:20
  • Talk-7

    Daniel Deme, Nógrád Vármegyei Szent Lázár Hospital, Hungary

    Title: Prognostic importance of peripheral blood biomarker combinations in advanced cancer

  • 14:20-14:40
  • Talk-8

    SPEAKER SLOT AVAILABLE

  • 14:40-15:00
  • Talk-9

    Manuel Algarra, Public University of Navarra, Spain

    Title: Carbon Nanoparticles as a New Gate to Improve the Cancer Therapy

     

  • 15:00-15:20
  • Talk-10

    Vimolmas Tansathitaya, Mahidol University, Thailand

    Title: Regulation of mi-RNAs Target Cancer Genes Between Exercise and Non-exercise in Rat Rheumatoid Arthritis Induction

  • 15:20-15:40
  • Talk-11

    SPEAKER SLOT AVAILABLE

  • 15:40-16:00
  • Talk-12

    Shairaz Baksh, Bio-Stream Diagnostics, Canada

    Title: Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation

  • 16:00-16:10
  • Refreshment Break

  • 16:10-16:30
  • Talk-13

    SPEAKER SLOT AVAILABLE

  • 16:30-16:50
  • Talk-14

    YuTe Liu, De-Yi Chinese Medicine Clinic/ Institute of Medicine, Chung Shan Medical University, Taiwan

    Title: In vitro and in vivo effects of traditional Chinese medicine formula T33 in human breast cancer cells 

  • 16:50-17:10
  • Talk-15

    SPEAKER SLOT AVAILABLE

day 2 agenda

Tue , Nov 07, 2023

  • 09:30 AM
  • Morning Session

    Morning Session

  • 09:30-09:50
  • Talk-1

    Raj Gopalan, BSRM Consulting, United States

    Title: Potential of Artificial Intelligence / Machine learning models to predict early the risk for Breast cancer by routibe blood markers

  • 09:50-10:10
  • Talk-2

    Sheila Fisher, Biotheranostics/Hologic, United States

    TBA

  • 10:10-10:30
  • Talk-3

    Hares Seddam, Batna2 University, Algeria

    Title: Study of the genetic predisposition to nasopharyngeal cancer in Algeria

  • 10:30-10:50
  • Talk-4

    Roja Rani Anupalli, Osmania University, India

    Title: Isolation and anticancer activity of quercetin from Acalypha indica L. against Breast cancer cell lines MCF‑7 and MDA‑MB‑231

  • 10:50-11:00
  • Refreshment Break

  • 11:00-11:20
  • Talk-5

    David Tasema Azako, Kinshasa University, Democratic republic of the congo

    Title: Epidemiological profile of cancer at the laboratory of anatomy and pathological cytology of mungbere in the Democratic Republic of Congo

  • 11:20-11:40
  • Talk-6

    SPEAKER SLOT AVAILABLE

  • 11:40-12:00
  • Talk-7

    Andrzej Bozek, Medical Univeristy of Silesia, Poland

    Title: Breast cancer and atopy

  • 12:00-12:20
  • Talk-8

    Yahia Saddek, Ahmed Ben Bella Oran 1 University,  Algeria

    Title: Expression profile of interleukin-6, 4-hydroxy-2-nonenal, and hypoxiainducible factor 1-α in women with breast cancer and their association with clinoco pathalogical parameters

  • 12:20-12:40
  • Talk-9

    SPEAKER SLOT AVAILABLE

  • 12:40-13:00
  • Talk-10

    SPEAKER SLOT AVAILABLE

  • 13:00-14:00
  • Lunch Break

  • 14:00-17:30
  • Posters

  • 14:00-14:20
  • Poster Presentation

    Rafael Colodetti, Federal University of Espirito Santo, Brazil

    Title: Breast cancer screening by spectroscopy through the analysis of plasma samples

  • 14:20-14:40
  • Poster Presentation

    SPEAKER SLOT AVAILABLE

  • 14:40-15:00
  • Poster Presentation

    Sonia Alves Gouvea, Federal University of Espirito Santo, Brazil

    Title: Prognostic value of pre-treatment cardiovascular biomarkers in breast cancer

  • 15:20-15:40
  • Poster Presentation

    SPEAKER SLOT AVAILABLE

  • 15:40-16:00
  • Poster Presentation

    Maria Teresa Martins De Araujo, Federal University of Espirito Santo, Brazil

    Title: Frequency of cardiovascular risk factors in patients with breast cancer

  • 16:00-16:20
  • Poster Presentation

    Chandrakanta Mahanty, GIET University, Gunupur, India

    Title: Breast Cancer Detection in Mammography Images Using Deep Convolutional Neural Networks and Fuzzy Ensemble Modeling Techniques 

  • 16:20-16:40
  • Poster Presentation

    Vinícius Mengal, Federal University of Espirito Santo, Brazil

    Title: Therapeutic potentials of L-arginine on the oxidative system in MCF-7 breast cancer cells

  • 16:40-16:50
  • Day-2 Concludes

Virtual agenda

Tue , Nov 07, 2023

  • Day -2: Nov (07, 2023)

    Virtual Presentations (Time zone: CET)

  • 11:00-11:20
  • Talk-1

    Yunyao Ye, Department of Oncology, Taizhou People’s Hospital, China

    Title: Breast metastases in advanced rectal cancer: a case report

  • 11:20-11:40
  • Talk-2

    Huan Wu, Chongqing Medical University, China

    Title: Construction of an Excellent 7 mRNAsi-Related Gene Model Based on Cancer Stem Cells for Predicting Survival Outcome of Cervical Cancer

     

  • 11:40-12:00
  • Talk-3

    SPEAKER SLOT AVAILABLE

  • 12:00-12:20
  • Talk-4

    Jianhua Zeng, Chongqing Medical University, China

    Title: Anoikis-related long non-coding RNA signatures to predict prognosis and small molecular drug response in cervical cancer

  • 12:20-12:40
  • Talk-5

    Qun Li, Shanghai East hospital of China, China

    Title: The delta subunit of the GABAA receptor is necessary for the GPT2-promoted breast cancer metastasis

  • 12:40-13:00
  • Talk-6

    Shiguang Zhao, The First Affiliated Hospital of Harbin Medical University, China

    Title: Natural product pectolinarigenin exerts anti-tumor effect on glioblastoma 

  • 13:00-13:20
  • Talk-7

    Sindhu Sankaran, Apollo Hospital, chennai, India

    Title: Efficacy of Degarelix in the Neoadjuvant Setting in Managing Locally Advanced Prostate Cancer

  • 13:20-13:40
  • Talk-8

    Agnieszka Misiarz, National Center for Nuclear Research, Poland

    Title: Aqure - new mobile accelerator for intraoperative radiotherapy with electrons –beam test results and future development

  • 13:40-14:00
  • Talk-9

    Maura Cardenas, BUAP, Mexico

    Title:Effect of heterosteroids derived from sapogenins in PI3K/AKT/mTOR and apoptosis pathways in breast cancer cells

  • 14:00-14:20
  • Talk-10

    SPEAKER SLOT AVAILABLE

  • 14:20-14:40
  • Talk-11

    Anne-Laurev Morel, TORSKAL, France

    Title: Plasmonic nanophotothermal therapy for the treatment of basal cell carcinoma with gold nanoparticles

  • 14:40-15:00
  • Talk-12

    SPEAKER SLOT AVAILABLE

  • 15:00-15:20
  • Talk-13

    Marianne E. Dubard-Gault, Fred Hutchinson Cancer Center, United States

    Title: Peer MD Coaching Partnership Outcomes Between an NCI-designated Cancer Center Genetics Service and a Community Cancer Network Hospital

  • 15:20-15:40
  • Talk-14

    SPEAKER SLOT AVAILABLE

  • 15:40-16:00
  • Talk-15

    Michael Goldstein, Johns Hopkins University, United States

    Title: Targeting H3K27me3 loss in pediatric brain tumors

  • 16:00-16:20
  • Talk-16

    Afua Richardson-Parry, Viatris, United kingdom

    Title: Interventions to reduce cancer screening inequities: the perspective and role of patients, advocacy groups, and empowerment organizations

  • 16:20-16:40
  • Talk-17

    Eric C. Chang, Baylor College of Medicine, United States

    Title: Tumor suppressor NF1 is a dual repressor of RAS and ER in breast cancer

  • 16:40-17:00
  • Talk-18

    Liang Liu, Wake Forest University School of Medicine, United States

    Title: Tumor microenvironment at single cell level in black and white NSCLC patients

  • 17:00-17:20
  • Talk-19

    Kayla Martinez, Ross University School of Medicine, Trinity Health Oakland Hospital, United States

    Title: High-grade DCIS arising from hyalinized fibroadenoma

  • 17:20-17:40
  • Talk-20

    Jay Desgrosellier, University of California, San Diego, United States

    Title: Breast cancer stem cells tolerate chromosomal instability during tumor progression via c-Jun/AXL stress signaling

  • 17:40-18:00
  • Talk-21

    Jung Su Yon, University of California, Los Angeles, United States

    Title: DNA methylation–based age acceleration as an early biomarker of breast cancer risk

WCCRT-2023 USA, San Diego Program